Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Ong G et al. – Regular low–dose aspirin may reduce all–cause and CVD mortality in a primary prevention setting in type 2 diabetes. All–cause mortality reductions appear greatest in men and those aged >=65 years. The present observational data support recommendations that aspirin should be used in primary CVD prevention in all but the lowest risk patients.
Related Articles
HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/19/09
Relevance Score: 93%
The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide Fixed-Dose Combination in the Reduction of Cardiovascular and Renal Events in Patients with Diabetes Mellitus
American Journal of Cardiovascular Drugs, 10/07/09
Relevance Score: 93%
Obesity Genotype Score and Cardiovascular Risk in Women With Type 2 Diabetes Mellitus
Arteriosclerosis, Thrombosis, and Vascular Biology, 11/17/09
Relevance Score: 89%
Vascular health in children and adolescents: effects of obesity and diabetes
Vascular Health and Risk Management, 11/11/09
Relevance Score: 89%
Value of C-reactive protein and IL-6 measurements in type 1 diabetes mellitus
Archives of Medical Science, 11/02/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
Diabetic Medicine, 02/09/10
OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10
Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10
Article Search
Sponsor
Sponsor